Literature DB >> 15019787

Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.

Edwin Pozharski1, Mark A Wilson, Anura Hewagama, Armen B Shanafelt, Gregory Petsko, Dagmar Ringe.   

Abstract

The crystal structures of an anti-morphine antibody 9B1 (to 1.6A resolution) and its complex with morphine (to 2.0 A resolution) are reported. The morphine-binding site is described as a shallow depression on the protein surface, an unusual topology for a high-affinity ( Ka approximately 10(9) M(-1)) antibody against a small antigen. The polar part of the ligand is exposed to solvent, and the cationic nitrogen atom of the morphine molecule is anchored at the bottom of the binding site by a salt-bridge to a glutamate side-chain. Additional affinity is provided by a double cation-pi interaction with two tryptophan residues. Comparison of the morphine complex with the structure of the free Fab shows that a domain closure occurs upon binding of the ligand.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019787     DOI: 10.1016/j.jmb.2003.12.084

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  The pH-dependent conformational states of kyotorphin: a constant-pH molecular dynamics study.

Authors:  Miguel Machuqueiro; António M Baptista
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

2.  Structure-guided residence time optimization of a dabigatran reversal agent.

Authors:  Felix Schiele; Joanne van Ryn; Tobias Litzenburger; Michael Ritter; Daniel Seeliger; Herbert Nar
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Constant-pH Molecular Dynamics Study of Kyotorphin in an Explicit Bilayer.

Authors:  Pedro R Magalhães; Miguel Machuqueiro; António M Baptista
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

4.  Short Carboxylic Acid-Carboxylate Hydrogen Bonds Can Have Fully Localized Protons.

Authors:  Jiusheng Lin; Edwin Pozharski; Mark A Wilson
Journal:  Biochemistry       Date:  2016-12-30       Impact factor: 3.162

5.  Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Reha Celikel; Eric C Peterson; S Michael Owens; Kottayil I Varughese
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

6.  Chemoinformatic methods for predicting interference in drug of abuse/toxicology immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Anthony F Pizon; Spiros Giannoutsos; Sean Ekins
Journal:  Clin Chem       Date:  2009-04-02       Impact factor: 8.327

7.  Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Sean Ekins
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

8.  Enhanced validation of small-molecule ligands and carbohydrates in the Protein Data Bank.

Authors:  Zukang Feng; John D Westbrook; Raul Sala; Oliver S Smart; Gérard Bricogne; Masaaki Matsubara; Issaku Yamada; Shinichiro Tsuchiya; Kiyoko F Aoki-Kinoshita; Jeffrey C Hoch; Genji Kurisu; Sameer Velankar; Stephen K Burley; Jasmine Y Young
Journal:  Structure       Date:  2021-03-02       Impact factor: 5.006

9.  Systematic Structure-Based Virtual Screening Approach to Antibody Selection and Design of a Humanized Antibody against Multiple Addictive Opioids without Affecting Treatment Agents Naloxone and Naltrexone.

Authors:  Chun-Hui Zhang; Kyungbo Kim; Zhenyu Jin; Fang Zheng; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2020-12-23       Impact factor: 4.418

10.  Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.

Authors:  Matthew D Krasowski; Anthony F Pizon; Mohamed G Siam; Spiros Giannoutsos; Manisha Iyer; Sean Ekins
Journal:  BMC Emerg Med       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.